06 Aug 2015
United Therapeutics Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 6, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 28, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30,...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 22, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2015 financial results before...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 29, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Dean Judy D. Olian, Ph.D. to its Board of Directors as...
SILVER SPRING, Md., and RESEARCH TRIANGLE PARK, N.C., June 15, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter from Watson...
29 May 2015
United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 29, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...
01 May 2015
United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 1, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 28, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 21, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2015 financial results before...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA), as part of the...
10 Mar 2015
FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved...